Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glutathione and protein thiol system in Plasmodium is a critical metabolic network responsible for maintaining redox equilibrium within the malaria parasite during its development inside host red blood cells. As the parasite consumes host hemoglobin, it releases large quantities of pro-oxidant heme and generates reactive oxygen species (ROS), making a robust antioxidant defense essential for its survival (Müller et al., 2003, PMID: 12831601). Glutathione (GSH) serves as the primary low-molecular-weight thiol that neutralizes ROS and maintains protein thiols in their functional reduced state, a process regulated by enzymes like glutathione reductase (GR) and glutamate-cysteine ligase (GCL) (Sarma et al., 2003, PMID: 12623524). Pharmacological targeting of this system, using agents such as methylene blue or buthionine sulfoximine, disrupts the parasite's ability to manage oxidative stress, leading to cellular damage and death (Becker et al., 2004, PMID: 15121182). While it is a promising therapeutic target, the high degree of similarity between parasite and host redox enzymes poses a significant challenge for achieving drug selectivity and avoiding host toxicity (Luersen et al., 2000, PMID: 10896311).
Inhibition of glutathione-dependent enzymes such as glutathione reductase and glutamate-cysteine ligase, or direct depletion of the reduced glutathione pool, leading to the accumulation of reactive oxygen species and lethal oxidative stress in the parasite.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione and protein thiol redox system (Plasmodium) (GSH/Protein-SH system).